A detailed history of Pdt Partners, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 31,402 shares of ALDX stock, worth $150,415. This represents 0.02% of its overall portfolio holdings.

Number of Shares
31,402
Holding current value
$150,415
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.19 - $6.32 $100,172 - $198,460
31,402 New
31,402 $169,000
Q2 2022

Aug 15, 2022

SELL
$2.43 - $4.85 $44,882 - $89,579
-18,470 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.25 - $5.17 $60,027 - $95,489
18,470 New
18,470 $82,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.